Gingium 240mg Film-Coated Tablets 60 pcs
High-dose Ginkgo biloba for memory, mental clarity, and circulation
Category: Cognitive Support / Circulation
Purpose: Enhances brain performance and blood flow in age-related cognitive issues
What It Is
Gingium 240mg by Hexal is a high-strength formulation containing 240 mg of standardized Ginkgo biloba extract (EGb 761) per tablet. It is clinically designed to improve memory, concentration, and circulation, particularly in adults with age-related cognitive decline. Gingium also helps alleviate associated symptoms such as dizziness, tinnitus, and cold extremities due to poor peripheral blood flow.
✅ Key Benefits
-
Supports memory and cognitive performance
-
Improves circulation in the brain and limbs
-
May reduce symptoms of tinnitus and dizziness
-
Provides antioxidant protection for nerve and brain cells
-
High-dose, once-daily convenience for long-term use
Use & Dosage
-
Adults: Take 1 tablet daily (240 mg) with water.
-
Can be taken with or without food.
-
Recommended duration of use: at least 8 weeks.
-
Do not exceed the stated dose.
⚠️ Safety & Precautions
-
Not recommended for individuals under 18 years.
-
Consult your doctor if taking blood thinners or before surgery.
-
Avoid during pregnancy and breastfeeding.
-
May increase bleeding risk in sensitive individuals.
-
Use under medical supervision, especially during long-term use.
Product Details
Form: Film-coated tablets
Active Ingredients: Ginkgo biloba extract (EGb 761), 240 mg
Target Group: Adults with memory, cognitive, or circulation concerns
Pack Size: 60 tablets (60-day supply)
Buy Gingium 240mg by Hexal
Support your cognitive function and circulation naturally with once-daily Gingium 240mg—available now in EU pharmacies.
SEO Keywords:
Gingium 240mg 60 tablets, Hexal Gingium Ginkgo biloba, high-dose ginkgo for memory, EGb 761 supplement EU, cognitive support tablets CZ, Gingium tinnitus treatment, herbal memory enhancer, Ginkgo biloba for circulation, Gingium Ginkgo 240 mg, natural brain support supplement
.
